News & Events
Nov 2013: Victor Chang Cardiac Research Institute acquires ExiProgenTM
Bioneer Pacific is pleased to announce that the Victor Chang Cardiac Research Institute (VCCRI) in Sydney has elected to acquire the ExiProgen™ Protein Synthesis and Purification system as a system platform critical for the acceleration of its protein research.
The following news release can be found at the Victor Chang Cardiac Research Institute website.
http://www.victorchang.edu.au/home/news-events/news/news-detail/?news_name=new-method-rapid-production-protein
NEW METHOD FOR RAPID PRODUCTION OF PROTEINS
A new instrument, the ExiProgenTM from Bioneer, is allowing scientists at the Victor Chang Cardiac Research Institute to rapidly compare normal proteins, the powerhouse of the body’s cells, with those found in diseases.
The ExiProgenTM enables scientists to manufacture and purify a protein within a cell-free in-vitro system, rather than using the traditional method, which involves expressing it from live cells.
Dr Romaric Bouveret said: “This instrument is the first of its kind in Australia. By using it to look at the structure of normal proteins, we hope we can then work backwards to better understand the effect of mutant proteins, responsible for different cardiovascular conditions including congenital heart disease.
“It allows us to look quickly at lots of different conditions which might affect the production and stability of proteins, including temperature.
“The machine has also been designed to enable the rapid purification of total DNA and RNA from cells, which means we can obtain high yields of ultra pure material very quickly. Although we haven’t explored these capabilities yet; we are very excited about doing so, and benefitting much more from the machine in the future.”
The Victor Chang Cardiac Research Institute was able to purchase the ExiProgenTM thanks to the generosity of Mrs Mimi Wong.
The Victor Chang Cardiac Research Institute is an independent, not-for-profit research facility, dedicated to the memory of cardiac surgeon Dr Victor Chang and his passionate belief in the power of discovery. Founded in 1994, the Institute has grown to become a world-class cardiac research and research training facility.
The ExiProgen™ system has been developed by Bioneer Corporation, a KOSDAQ listed company based in Daejeon, South Korea.
Feb 2013: Bernice Tan joins Bioneer Pacific
Bernice Tan has joined Bioneer Pacific as a Sales & Applications Specialist. Bernice studied at the University of New South Wales and comes to us having recently completed her PhD at the Garvan Institute of Medical Research. She has considerable depth and experience in many aspects of molecular biology, including protocol optimisation and troubleshooting which is sure to add substantial value for our customers when considering and selecting products from the Bioneer Pacific product range for their research. Welcome Bernice.
Feb 2013: Bioneer Pacific at the Lorne Genome Conference
Bioneer Pacific will be participating at the 34th Annual Lorne Genome Conference at the Mantra Lorne Resort Feb 17th – 19th.
We will be showcasing the ExiProgen™ ‘cell-free’ protein synthesis and purification system in addition to our comprehensive range of Amplification kits and Enzymes.
Please drop by to see us at booth #4 to meet us and to pick up your 10% discount Coupon Code in celebration of the launch of our new Australian website. The Coupon Code can be used right across the product range and includes online ordering of Oligos.
]]>